FFilingSight

UnitedHealth Group (UNH) 10-K Red Flags

Risk signals extracted deterministically from UnitedHealth Group’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (14)

  • Inventory buildup exceeds sales growth: Inventory grew +35.7% vs revenue +14.6%. Excess inventory may signal weakening demand, potential write-downs, or supply chain overcommitment. Watch gross margin for discounting impact.
  • Material weakness in internal controls: The term "material weakness" appears in 23 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
  • NEW: Restatement of financial statements in latest filing: The term "restate" "financial statements" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 9 filing(s).
  • Operating cash flow exceeds net income: OCF is 1.30x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • Goodwill is 35% of total assets: Goodwill of $110.51B represents a large share of the balance sheet. If acquired businesses underperform, a non-cash impairment charge could materially impact earnings. Monitor segment performance and acquisition integration metrics.
  • NEW: Impairment charge: Impairment charge appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • Endogenous analysis: 3 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 4 new risk-language term(s) detected in filing text: Restatement of financial statements, Impairment charge, Restructuring, Off-balance sheet arrangements.
  • Ongoing high-severity risk language: Material weakness in internal controls.
  • Composite risk: Elevated.
  • Leverage debt/equity 2.16 (high).
  • Inventory buildup exceeds sales growth: Inventory grew +35.7% vs revenue +14.6%. Excess inventory may signal weakening demand, potential write-downs, or supply chain overcommitment. Watch gross margin for discounting impact.
  • Material weakness in internal controls: The term "material weakness" appears in 23 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.

Filings & ownership

  • Latest annual report (10-K) filed Mar 2, 2026.
  • Latest quarterly report (10-Q) filed May 5, 2026.
  • 12 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference UnitedHealth Group; broad institutional reporting.
  • Recent filers include Capital Wealth Planning, LLC, Capital Wealth Planning, LLC, Capital Wealth Planning, LLC.
  • 4 recent 13D activist/beneficial-ownership filings — potential catalyst.
  • 16 recent 13G passive institutional ownership notices.

Full UNH analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.